Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Osteotech
Eatontown, New Jersey, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Osteotech was a global leader in processing human bone and connective tissue for transplantation. The company developed innovative biologic, biomaterial, and device systems for musculoskeletal surgery with a focus on spinal, trauma, and total joint revision procedures. Its key products included Grafton demineralized bone matrix and MagniFuse bone grafts. In August 2010, Osteotech was acquired by Medtronic.
- Therapeutic areas
- NeurologyRheumatologyOther
- Modalities
- BiologicBiomaterialDevice
- Industry
- Implantable Medical Devices
02
Partnerships
Musculoskeletal Transplant Foundation (MTF)
Beyond the preview
Go deeper on Osteotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Osteotech.